Altrubio

Abivax

This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.

Granite Bio

This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Sorriso

This biopharmaceutical company develops oral antibody therapeutics to treat patients with immune-mediated diseases such as Crohn's disease and ulcerative colitis.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

Aeglea BioTherapeutics

This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.

AllInBio

The company develops precision immunology therapies to identify and treat patients genetically predisposed to chronic inflammatory and autoimmune diseases.